Medicine

The Pope, during a visit to the French shrine town of Lourdes, declared that 'medicine must never be servant of programmed death', a pointed comment on debates over euthanasia and assisted dying. The remark came in the context of the shrine's association with healing and pilgrimage, and it signals the Vatican's continued opposition to legalised ending of life on medical grounds.

The Trump administration is retreating from a plan to exert greater control over National Institutes of Health grant decisions after significant pushback. A proposed executive order that would have increased White House oversight of NIH funding appears to be dead, according to reporting by Semafor, marking a setback for efforts to centralise control of federal biomedical research grants.

Stanford Medicine is being widely cited for a claim that the human brain is actually two organs rather than one. The finding, reported by KRON 4, has drawn large public attention as audiences debate what a two-organ model would mean for neuroscience and medicine. Details of the underlying research have not been made available in the coverage cited.

An obesity medicine doctor is addressing the growing trend of taking small, lower-than-prescribed doses of Ozempic, the weight-loss and diabetes drug semaglutide. The expert explains the potential risks of adjusting doses without medical guidance, including reduced effectiveness and side effects, while noting the limited circumstances where a low dose may genuinely make sense for some patients.

Atrial fibrillation patients who take common blood thinners saw a 69% lower risk, according to newly reported findings circulating in health news. The claim concerns widely used anticoagulants and their protective effect in people with the heart rhythm condition. No further details on the study's size, population or methodology were available in the coverage, so the exact scope of the finding remains to be confirmed.

GLP-1 weight-loss drugs such as Ozempic and Wegovy are reshaping sleep medicine, with clinicians reporting improved sleep apnea symptoms in patients losing significant weight and drugmakers seeking apnea indications. Sleep specialists are debating whether medication could reduce reliance on CPAP machines, while researchers caution that long-term effects on sleep disorders remain largely unstudied.

A debate is unfolding over legal accountability when artificial intelligence systems make errors in medical care. As AI tools move into diagnosis, treatment recommendations and clinical workflows, doctors, hospitals and technology developers are all potential defendants. The core question: does responsibility rest with the physician who followed the algorithm, the hospital that deployed it, or the company that built it. Legal frameworks have not kept pace.

New research reported by SciTechDaily suggests that losing the same amount of weight does not produce identical health benefits for everyone. The findings point to individual variation in how the body responds to weight loss, meaning two people with the same result may see different improvements in metabolic or cardiovascular health. The story is drawing attention for challenging the assumption that weight loss alone reliably translates into uniform health gains.

Minnesota Vikings wide receiver Justin Jefferson exited the team's game against the Tampa Bay Buccaneers after suffering an ankle injury. The severity of the injury was not immediately clear, and fans await updates on how long the star receiver might be sidelined and what it means for the Vikings' offense going forward.

A forum letter in Singapore's The Straits Times argues that patients who combine Western medicine with traditional Chinese medicine should be guided by professional judgment rather than outright prohibitions. The writer says blanket bans ignore real patient behaviour, and that doctors should instead assess interactions and advise patients openly on how to use both systems safely.

Minnesota Vikings star wide receiver Justin Jefferson has been ruled out for the game against the Tampa Bay Buccaneers due to an ankle injury. His absence is a significant blow to Minnesota's offence, as Jefferson is one of the NFL's top playmakers. Fans and analysts are watching closely for updates on how long he may be sidelined.

A South China Morning Post piece examines the risks of combining traditional Chinese medicine with Western prescription drugs, warning that interactions between herbal remedies and pharmaceuticals can reduce drug effectiveness or cause harmful side effects. The article urges patients to tell their doctors about any herbal treatments they use, as these are often undisclosed and can interact with common medications.

Josh Allen and the Buffalo Bills beat the Los Angeles Chargers 24-16 despite committing five turnovers. The win came despite sloppy play on offense, with the Bills surviving repeated giveaways that would typically prove costly. Buffalo's defense and key plays proved enough to hold off Los Angeles and secure the result.

Dan Wilson is no longer manager of the Seattle Mariners, the club having parted ways with the former catcher who led the team. The news, first reported by Medicine Hat News, comes as the Mariners make a change at the top of their dugout. Details on the timing of the decision and who might replace Wilson have not yet been announced.

New reporting indicates that people with insomnia face a higher risk of stroke, adding to growing evidence that sleep problems affect long-term cardiovascular health. The findings are being discussed as a reminder that chronic sleeplessness should be treated as a medical concern rather than a minor annoyance, with potential implications for prevention and patient screening.

Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.

Platform trials, which test multiple treatments against a single control group, are changing how clinical evidence is generated in medicine. Commentators argue that regulators have not yet adapted their standards to this trial design, raising questions about how such evidence will be assessed for drug approvals.